Abstract #3574

Feasibility of Imaging Lung Cancer Using Hyperpolarized MRI Technology

Mehrdad Pourfathi¹, Luis Loza¹, Stephen Kadlecek¹, Ian Duncan¹, Diane Lim², Shampa Chatterjee³, Kai Ruppert¹, Sarmad Siddiqui¹, Harrilla Profka¹, Yan Liu², Jessica Kim², Hooman Hamedani¹, Yi Xin¹, Faraz Amzajerdian¹, Maurizio Cereda⁴, Ryan Baron¹, Mary Spencer¹, Tahmina Achekzai¹, Jose Conejo-Garcia⁵, and Rahim R. Rizi¹

¹Radiology, University of Pennsylvania, Philadelphia, PA, United States, ²Sleep Medicine, University of Pennsylvania, Philadelphia, PA, United States, ³Physiology, University of Pennsylvania, Philadelphia, PA, United States, ⁴Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, PA, United States, ⁵Moffitt Cancer Center, Tampa, FL, United States

We demonstrate the feasibility of hyperpolarized MRI technology to image lung cancer in mice. We demonstrated the use of ¹³C MRSI to detect elevated pyruvate to lactate conversion in the tumor relative to the adjacent non-cancerous lung tissue. We also showed the feasibility of ¹²⁹Xe imaging to detect non-aerated regions in the lung tissue co-localized with the tumor. The utility of these modalities combined may provide a multi-faceted tool to assess tumor's stage and its response to therapy in lung cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.